99 — 8 (46) 2022 — Prof. Shibanova A.I., Belamanova L.Zh., Koshmagambetova M.Sh., PROBLEMS OF ORGANIZATION AND WAYS TO INCREASE THE EFFICIENCY OF WOMEN’S SCREENING FOR DETECTION CERVICAL CANCER IN THE REPUBLIC OF KAZAKHSTAN

PROBLEMS OF ORGANIZATION AND WAYS TO INCREASE THE EFFICIENCY OF WOMEN’S SCREENING FOR DETECTION CERVICAL CANCER IN THE REPUBLIC OF KAZAKHSTAN

Prof. Shibanova A.I., Laboratory of Cytology KazNIIOiR, City pathoanatomical bureau of Almaty city

Belamanova L.Zh., Laboratory of Cytology KazNIIOiR, City pathoanatomical bureau of Almaty city

Koshmagambetova M.Sh., Laboratory of Cytology KazNIIOiR, City pathoanatomical bureau of Almaty city

Resume

Cervical cancer (CC) is one of the urgent problems of modern oncogynecology. According to the incidence and mortality rates from cancer in the Republic of Kazakhstan, cervical cancer is at the forefront and cervical cancer screening is one of the most effective ways to detect precancerous and neoplastic lesions of the cervix.

A selective analysis (2008-2012, 2013-2017) of cytological material for screening for cervical cancer in the Republic of Kazakhstan shows that a huge number of women with diagnoses of cervical cancer, an early form of cervical cancer were detected using the cytological method for the first time (carcinoma in situ), intraepithelial neoplasia (CIN I, CIN II, CIN III).

According to the examination algorithm, women diagnosed with cervical cancer and cancer in situ are immediately referred for special treatment. However, the group of women with intraepithelial neoplasia CIN II, CIN III and positive for HPV remains under-researched.

Therefore, the new technology proposed by the authors with the determination of p16/Ki-67, registration and monitoring of all women who have passed screening is the next step to detect early forms of cervical cancer.

Key words: Cervical cancer, cytological method for diagnosing cervical cancer, carcinoma in situ), intraepithelial neoplasia (CIN I, CIN II, CIN III), new technology with p16/Ki-67 detection, registration and monitoring of all women.

First page

605

Last page

609

For citation: Prof. Shibanova A.I., Belamanova L.Zh., Koshmagambetova M.Sh., PROBLEMS OF ORGANIZATION AND WAYS TO INCREASE THE EFFICIENCY OF WOMEN’S SCREENING FOR DETECTION CERVICAL CANCER IN THE REPUBLIC OF KAZAKHSTAN //New Day in Medicine 8(46)2022 https://l.clck.bar/79c8d

LIST OF REFERENCES:

1. Показатели онкологической службы Республики Казахстан за 2014 год (статистические материалы). – Министерство здравоохранения РК, Казахский научно-исследовательский институт онкологии и радиологии. – Алматы, 2015.
2. Показатели онкологической службы Республики Казахстан за 2015 год (статистические материалы). – Министерство здравоохранения Республики Казахстан, Казахский научно-исследовательский институт онкологии и радиологии. – Алматы, – 2016.
3. Bergeron Christine, von Knebel Doeberitz Magnus. The Role of Cytology in the 21st Century: The Integration of Cells and Molecules. Acta Cytologica, 2016, №6, p.540-542.
4. Bergeron C., Ronco G., Reuschenbach M., et al. The clinical impact of using p16 immunochemistry in cervical histopathology and cytology: an update of recent developments. // Int.J.Cancer, 2014, v.136, p.2741-2751.
5. Reuschenbach M., Seiz M., von Knebel Doeberitz C., et al. Evaluation of cervical cone biopsies for coexpression of p16 and Ki-67 in epithelial cells. // Int.J.Cancer, 2012, v.130, p.388-394.
6. Schmidt D., Bergeron C., Denton K., Ridder R. p16/Ki-67 dual-stain cytology in the triage of ASCUS and LSIL Papanicolau cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study. // Cancer Cytopathol., 2011, v.119, p.158-166.
7. Waldstrom M., Kolby Christensen R., Ornskov D. Evaluation of p16/Ki-67 dual stain in comparison with an mRNA human papillomavirus test on liquid-based cytology samples with low-grade squamous intraepithelial lesion. // Cancer Cytopathol., 2013, v.121, p.136-145.
8. Ronco G., Dillner J., Elfstrom K., et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomized controlled trials. // Lancet, 2014, v.383, p.524-532
9. Carozzi F., Gillio-Tos A., Confortini M., et al. Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16INK4A results: a prospective analysis of a nested substudy of the NTCC randomized controlled trial. // Lancet, Oncol., 2013, v.14, p.168-176.